SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 22nd, 2020 • Cyclacel Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 22nd, 2020 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of December 18, 2020, is by and among Cyclacel Pharmaceuticals, Inc., a Delaware corporation with headquarters located at 200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey 07922 (the “Company”), and Acorn Bioventures, L.P., a Delaware limited partnership (the “Buyer”).